EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode 5-moUTP Report
2026-07-03
EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) enables dual bioluminescent and fluorescent tracking in mRNA delivery and transfection studies. Its Cap1 capping and 5-moUTP modifications increase translation efficiency and reduce immune activation, providing robust, real-time assessment of intracellular mRNA fate.
Morning Exercise Drives Superior Endurance Adaptation in Mic
2026-07-03
Hesketh et al. demonstrate that endurance training during the early active (morning) phase elicits more efficient performance and skeletal muscle adaptations in mice than equivalent afternoon training, even with lower absolute workloads. These findings highlight the critical role of exercise timing in shaping endurance adaptation and inform experimental approaches in circadian and metabolic physiology.
Caffeic Acid Phenethyl Ester (CAPE): Unraveling NF-κB and St
2026-07-02
Explore how Caffeic Acid Phenethyl Ester (CAPE) acts as a precise NF-κB inhibitor and modulator of Stat3 signaling, offering unique insights for tumor invasion and neurodegeneration studies. This in-depth article goes beyond standard workflows to bridge mechanistic findings with practical assay design.
Dimetridazole as a Next-Gen Quorum Sensing Inhibitor in Anti
2026-07-02
Explore the multifaceted role of Dimetridazole as a quorum sensing inhibitor and biofilm suppressor. This article delves into new mechanistic insights and practical assay implications, offering a deeper perspective beyond traditional antimicrobial applications.
Tacalcitol Monohydrate: Precision Tools for NGF and Cancer A
2026-07-01
Explore how Tacalcitol monohydrate, a synthetic analog of vitamin D3, enables advanced, protocol-driven research in NGF induction and oncology. Learn how optimized parameters and mechanistic insight set this compound apart for translational applications.
CFTRinh-172: Reliable CFTR Inhibition for Epithelial Assays
2026-07-01
This article delivers scenario-driven guidance for researchers using CFTRinh-172 (SKU B1435) to address experimental challenges in epithelial cell assays. Learn how its specificity, rapid action, and validated protocols support reproducible CFTR inhibition across cystic fibrosis and secretory diarrhea models. Evidence-backed recommendations help scientists optimize workflows and interpret data with confidence.
NU7441 (KU-57788): Precision DNA-PK Inhibition in Cancer Res
2026-06-30
NU7441 (KU-57788) is a potent, ATP-competitive, and selective DNA-PK inhibitor with subnanomolar binding affinity and minimal off-target kinase activity. It is widely used in DNA repair and oncology research, enabling robust cell cycle arrest and sensitization of cancer cells to DNA-damaging agents. APExBIO provides validated protocols and high-purity NU7441 (A8315) for reproducible laboratory results.
Etoposide (VP-16): Optimizing DNA Damage Assays in Cancer Ce
2026-06-30
Etoposide (VP-16) empowers researchers to dissect DNA double-strand break pathways and apoptosis induction in cancer cells with precision. This guide translates bench research and new nuclear cGAS insights into actionable protocols, troubleshooting, and advanced applications using Etoposide from APExBIO.
cgSHAPE-seq Maps RNA-Degrading Chimera Sites in SARS-CoV-2 5
2026-06-29
This study introduces chemical-guided SHAPE sequencing (cgSHAPE-seq) to pinpoint ligand binding sites within the conserved 5′ untranslated region (UTR) of the SARS-CoV-2 RNA genome. The method enables precise mapping of small molecule–RNA interactions, facilitating the rational design and optimization of RNA-degrading chimeras with antiviral activity.
ECL Western Blotting Substrate: Protocol, QC, and Troublesho
2026-06-29
ECL Western Blotting Substrate (SKU K2187) is a nonradioactive, luminol-based reagent optimized for the detection of HRP-conjugated proteins via chemiluminescence. It provides a sensitive and clear alternative to radioactive methods in Western blot assays, but is not suitable for fluorescent or radioisotopic applications.
Safe DNA Gel Stain: Enhancing DNA and RNA Gel Stain Workflow
2026-06-28
Safe DNA Gel Stain from APExBIO enables high-sensitivity nucleic acid detection while reducing mutagenic risk and DNA damage compared to ethidium bromide. Its compatibility with blue-light excitation and streamlined protocols boosts cloning efficiency and lab safety, setting a new standard for DNA and RNA gel workflows.
Etomoxir: Mechanisms and Protocols in Fatty Acid Oxidation R
2026-06-27
Etomoxir is a potent, irreversible CPT-1 inhibitor widely used to dissect the fatty acid oxidation pathway in metabolic and immunometabolism research. Its specificity and in vivo efficacy make it a cornerstone for studying lipid metabolism and related immune responses. Clinical and preclinical benchmarks confirm its precise action profile and application boundaries.
Br-DAPI: Advanced DAPI Fluorescent Dye for DNA Quantificatio
2026-06-26
Br-DAPI redefines DNA staining by combining robust fluorescence amplification with exceptional cell permeability, enabling precise quantification in both live and fixed cell assays. Its optimized workflow accelerates imaging and reduces background, making it the preferred choice for high-sensitivity research applications.
Apigenin: Strategic HDAC Inhibition for Translational Oncolo
2026-06-26
This thought-leadership article offers a comprehensive, mechanistic, and strategic exploration of Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) as a next-generation HDAC inhibitor for translational research in oncology—specifically malignant mesothelioma—and neurodegenerative disorders like Alzheimer’s disease. By integrating direct comparisons to both the competitive landscape and recent network medicine findings, it provides actionable guidance for assay design, highlights critical protocol parameters, and outlines translational milestones, moving beyond conventional product summaries to deliver a uniquely forward-looking, evidence-based resource for the research community.
Metoprolol in Translational Research: Beyond Beta-Blockade
2026-06-25
Explore how Metoprolol, a selective beta1-adrenoceptor antagonist, advances cardiovascular and cancer biology research. This article delivers a deep scientific analysis, distinct from existing resources, and reveals emerging applications in inflammation and angiogenesis studies.
458 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page